WP
PVLA

Woodline Partners’s Palvella Therapeutics PVLA Stock Holding History

Woodline Partners’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.5M Hold
317,517
– – 0.15% 180
2026
Q1 		$39.6M Buy
317,517
+16,981
+6% +$1.77M 0.15% 178
2025
Q4 		$31.5M Sell
300,536
-45,213
-13% -$3.86M 0.12% 217
2025
Q3 		$21.7M Sell
345,749
-99,866
-22% -$4.45M 0.1% 265
2025
Q2 		$10M Buy
445,615
+251,448
+130% +$5.9M 0.05% 434
2025
Q1 		$5.43M Buy
+194,167
New +$3.74M 0.04% 486
2022
Q2 		– Sell
-19,843
Closed -$4.81M – 905
2022
Q1 		$4.81M Sell
19,843
-10,953
-36% -$2.88M 0.08% 250
2021
Q4 		$9.31M Buy
+30,796
New +$9.86M 0.13% 207
2021
Q2 		– Sell
-6,231
Closed -$1.28M – 635
2021
Q1 		$1.28M Sell
6,231
-8,169
-57% -$1.79M 0.03% 348
2020
Q4 		$2.88M Sell
14,400
-4,759
-25% -$990K 0.08% 183
2020
Q3 		$3.17M Sell
19,159
-1,858
-9% -$423K 0.1% 152
2020
Q2 		$5.21M Buy
21,017
+7,954
+61% +$1.86M 0.21% 111
2020
Q1 		$2.38M Buy
+13,063
New +$3.29M 0.17% 113

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Woodline Partners's PVLA Position: Q2 2026 in Review

Woodline Partners held its Palvella Therapeutics (PVLA) position steady in Q2 2026 at 317,517 shares worth $48.5M. The position accounts for 0.15% of the portfolio, ranked #180.

Woodline Partners first reported a position in PVLA in Q1 2020 and has held it in 13 quarters since. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Woodline Partners held 317,517 shares of Palvella Therapeutics worth $48.5M as of Q2 2026.
  • Woodline Partners left its Palvella Therapeutics share count unchanged in Q2 2026.
  • Palvella Therapeutics made up 0.15% of Woodline Partners's portfolio in Q2 2026, its #180 holding.
  • Woodline Partners first reported a position in Palvella Therapeutics in Q1 2020 and has held it in 13 quarters since.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.